OFELIA RODRIGUEZ

Allopathic & Osteopathic Physicians|Internal Medicine MCALLEN, TX NPI 1528010147

General Payments — all program years on this page

$4,572.09

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 118
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $584.76 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $584.7617

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $1,108.7825
2019 $806.2314
2020 $338.9822
2021 $1,055.0320
2022 $533.4013
2023 $144.917
2024 $584.7617

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096693727 Novo Nordisk Inc $19.55 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096922708 Novo Nordisk Inc $115.38 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096997195 Novo Nordisk Inc $1.95 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097028162 Novo Nordisk Inc $17.37 07/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097052843 Novo Nordisk Inc $14.52 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104678765 AstraZeneca Pharmaceuticals LP $13.82 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105964858 ABBVIE INC. $124.99 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114858930 Exact Sciences Corporation $20.34 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116735922 GlaxoSmithKline, LLC. $15.64 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118043944 Boehringer Ingelheim Pharmaceuticals, Inc. $19.56 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118043946 Boehringer Ingelheim Pharmaceuticals, Inc. $111.03 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135180119 Lilly USA, LLC $19.43 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135267531 Lilly USA, LLC $13.32 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135267536 Lilly USA, LLC $18.09 07/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135309568 Lilly USA, LLC $22.75 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135309571 Lilly USA, LLC $18.31 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148910874 Sumitomo Pharma America, Inc. $18.71 09/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.